0 items USD 0.00Search
Your search for "globaldata chronic myelocytic leukemia cml chronic myeloid leukemia global clinical trials review h1" gave back 757545 results.
Accumulation of functionally incompetent monocytes is referred as Chronic Lymphocytic Leukemia (CLL). Chronic Lymphocytic Leukemia is a type of...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
Chronic Lymphocytic Leukemia (CLL) is a type of hematological malignancy marked by excessive proliferation of abnormal white blood cells. CLL...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Market Analysis and Insights: Global Chronic Lymphocytic Leukemia Therapeutics Market The global Chronic Lymphocytic Leukemia Therapeutics market is...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Accumulation of functionally incompetent monocytes is referred as Chronic Lymphocytic Leukemia (CLL). Chronic Lymphocytic Leukemia is a type of...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
Tioguanine, also known as thioguanine or 6-thioguanine (6-TG) is a medication used to treat acute myeloid leukemia (AML), acute lymphocytic leukemia...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Chronic Lymphocytic Leukemia (CLL) is a type of hematological malignancy marked by excessive proliferation of abnormal white blood cells. CLL...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Market Analysis and Insights: Global B-Cell Chronic Lymphocytic Leukemia Treatment Market The global B-Cell Chronic Lymphocytic Leukemia Treatment...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
The global Pharmerging market size is expected to reach US$ 1640.1 million by 2029, growing at a CAGR of 8.7% from 2023 to 2029. The market is mainly...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Dasatinib, sold under the brand name Sprycel, is a chemotherapy medication used to treat certain cases of chronic myelogenous leukemia (CML) and...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Ponatinib HCl, also known by its brand name Iclusig, is a medication used in the treatment of certain types of cancer. It belongs to a class of drugs...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Imatinib is a chemotherapy drug that acts by reducing or preventing the progression of cancer cells. This drug is used for the treatment of certain...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Relapsed Acute Myeloid Leukemia Drug market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
The global Adult T-Cell Leukemia/Lymphoma Treatment market size was valued at USD 127.2 million in 2023 and is forecast to a readjusted size of USD...
Catalog:
GIR
January 2024
Price: USD 3,480.00
